Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-9.94
↓ 274% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive growthContracting
Average
-2.66
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -9.94 | +14.2% |
| 2024 | -11.57 | -124.8% |
| 2023 | -5.15 | -71.2% |
| 2022 | -3.01 | -74.7% |
| 2021 | -1.72 | -10.8% |
| 2020 | -1.55 | -1282.0% |
| 2019 | -0.11 | +78.1% |
| 2018 | -0.51 | -105.0% |
| 2017 | 10.26 | +413.2% |
| 2016 | -3.27 | - |